Key result
MiRP2 stabilizes activated KCNQ1 voltage sensors via a lipomimetic mechanism using D54 and D55 residues.
MiRP2 uses a lipomimetic mechanism by providing negative charge near the plasma membrane extracellular face to constitutively stabilize the activated KCNQ1 voltage sensor.
No immediate clinical implications; leaves open whether this mechanism informs human arrhythmia therapies or drug design.
The low-dielectric plasma membrane provides an energy barrier hindering transmembrane movement of charged particles. The positively charged, voltage-sensing fourth transmembrane domain (S4) of voltage-gated ion channels must surmount this energy barrier to initiate channel activation, typically necessitating both membrane depolarization and interaction with membrane lipid phospho-head groups (MLPHGs). In contrast, and despite containing S4, the KCNQ1 K(+) channel alpha subunit exhibits predominantly constitutive activation when in complexes with transmembrane beta subunits, MinK-related peptide (MiRP) 1 (KCNE2) or MiRP2 (KCNE3). Here, using a 2-electrode voltage clamp and scanning mutagenesis of channels heterologously expressed in Xenopus laevis oocytes, we discovered that 2 of the 8 MiRP2 extracellular domain acidic residues (D54 and D55) are important for KCNQ1-MiRP2 constitutive activation. Double-mutant thermodynamic cycle analysis revealed energetic coupling of D54 and D55 to R237 in KCNQ1 S4 but not to 10 other native or introduced polar residues in KCNQ1 S4 and surrounding linkers. MiRP2-D54 and KCNQ1-R237 also similarly dictated susceptibility to the inhibitory effects of MLPHG hydrolysis, whereas other closely situated polar residues did not. Thus, by providing negative charge near the plasma membrane extracellular face, MiRP2 uses a lipomimetic mechanism to constitutively stabilize the activated KCNQ1 voltage sensor.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2009) studied this question. Scanning mutagenesis of KCNQ1-MiRP2 channels was evaluated on Energetic coupling and susceptibility to inhibitory effects of MLPHG hydrolysis. MiRP2 uses a lipomimetic mechanism to constitutively stabilize the activated KCNQ1 voltage sensor by providing negative charge near the plasma membrane extracellular face via D54 and D55 residues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: